<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Neurotrope, Inc.</title><link>https://investorshangout.com/Neurotrope-Inc-NTRP-87968/</link><description><![CDATA[Neurotrope, Inc. (NTRP)]]></description><language>en-us</language><pubDate>Thu, 03 Sep 2026 02:30:24 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Neurotrope-Inc-NTRP-87968/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $NTRP News Article - 5 Penny Stocks Gaining Momentum This Week; 1 Up Over 150% </title><link>https://investorshangout.com/post/view?id=5650847</link><guid>https://investorshangout.com/post/view?id=5650847</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 22 Jan 2020 15:25:42 GMT</pubDate></item><item><title>whytestocks: $NTRP News Article - Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder V</title><link>https://investorshangout.com/post/view?id=5559154</link><guid>https://investorshangout.com/post/view?id=5559154</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 08 Oct 2019 13:20:41 GMT</pubDate></item><item><title>whytestocks: $NTRP News Article - Neurotrope Appoints Dr. Michael Ciraolo As General Counsel And Chief Operating </title><link>https://investorshangout.com/post/view?id=5398936</link><guid>https://investorshangout.com/post/view?id=5398936</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 01 Apr 2019 15:50:41 GMT</pubDate></item><item><title>whytestocks: $NTRP News Article - Neurotrope Comments On Biogen&#039;s Discontinued Phase 3 Trial In Alzheimer&#039;s Disea</title><link>https://investorshangout.com/post/view?id=5387104</link><guid>https://investorshangout.com/post/view?id=5387104</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 21 Mar 2019 14:05:40 GMT</pubDate></item><item><title>whytestocks: $NTRP News Article - Neurotrope Completes Enrollment Of Confirmatory Phase 2 Study of Bryostatin-1 i</title><link>https://investorshangout.com/post/view?id=5378216</link><guid>https://investorshangout.com/post/view?id=5378216</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 13 Mar 2019 19:50:40 GMT</pubDate></item><item><title>F1ash: It was always riskier than AVXL. Showing actual results that can highlight the lack of a dose respo</title><link>https://investorshangout.com/post/view?id=4518971</link><guid>https://investorshangout.com/post/view?id=4518971</guid><description><![CDATA[F1ash
]]></description><pubDate>Mon, 01 May 2017 20:33:53 GMT</pubDate></item><item><title>chemist823: Pulled out, 50% gain not bad but wish it was better news.</title><link>https://investorshangout.com/post/view?id=4518050</link><guid>https://investorshangout.com/post/view?id=4518050</guid><description><![CDATA[chemist823
]]></description><pubDate>Mon, 01 May 2017 14:08:00 GMT</pubDate></item><item><title>F1ash: Ok check this out Sent this to Jeff yesterday. (IR at Neurotrope) &quot;Hello Jeff, I hear Neurotrope</title><link>https://investorshangout.com/post/view?id=4512925</link><guid>https://investorshangout.com/post/view?id=4512925</guid><description><![CDATA[F1ash
]]></description><pubDate>Fri, 28 Apr 2017 12:33:47 GMT</pubDate></item><item><title>F1ash: Let&#039;s hope for a Monday news release instead of a Friday. Exciting times dead ahead, no matter how</title><link>https://investorshangout.com/post/view?id=4499611</link><guid>https://investorshangout.com/post/view?id=4499611</guid><description><![CDATA[F1ash
]]></description><pubDate>Fri, 21 Apr 2017 21:03:33 GMT</pubDate></item><item><title>Triple9: BRIEF-Neurotrope files for mixed shelf of up to $100 million BY Reuters — 5:40 PM ET 03/31/2017 </title><link>https://investorshangout.com/post/view?id=4455637</link><guid>https://investorshangout.com/post/view?id=4455637</guid><description><![CDATA[Triple9
]]></description><pubDate>Sat, 01 Apr 2017 15:42:03 GMT</pubDate></item><item><title>NotRichYet2: Well can only guess on a pullback . Good job though on taking out that concern for you. A pullback </title><link>https://investorshangout.com/post/view?id=4379331</link><guid>https://investorshangout.com/post/view?id=4379331</guid><description><![CDATA[NotRichYet2
]]></description><pubDate>Sun, 26 Feb 2017 19:43:33 GMT</pubDate></item><item><title>chemist823: NTRP-I&#039;ll let the house money shares ride, probably into trial results in April. If there is a pullb</title><link>https://investorshangout.com/post/view?id=4375973</link><guid>https://investorshangout.com/post/view?id=4375973</guid><description><![CDATA[chemist823
]]></description><pubDate>Thu, 23 Feb 2017 19:14:34 GMT</pubDate></item><item><title>chemist823: NTRP- I sold some today, had almost a double here and will see if there is a pull back to repurchase</title><link>https://investorshangout.com/post/view?id=4374611</link><guid>https://investorshangout.com/post/view?id=4374611</guid><description><![CDATA[chemist823
]]></description><pubDate>Thu, 23 Feb 2017 15:14:19 GMT</pubDate></item><item><title>NotRichYet2: Right now , for my own purposes , I am discounting the market cap as a none meaningful factor till r</title><link>https://investorshangout.com/post/view?id=4371897</link><guid>https://investorshangout.com/post/view?id=4371897</guid><description><![CDATA[NotRichYet2
]]></description><pubDate>Wed, 22 Feb 2017 13:41:20 GMT</pubDate></item><item><title>chemist823: NTRP- Yes heading higher. The market cap even with the latest moves is only 125 million. I think tha</title><link>https://investorshangout.com/post/view?id=4371753</link><guid>https://investorshangout.com/post/view?id=4371753</guid><description><![CDATA[chemist823
]]></description><pubDate>Wed, 22 Feb 2017 12:40:54 GMT</pubDate></item><item><title>NotRichYet2: Well it is heading UP for sure . Last was 18.41 up 2.64</title><link>https://investorshangout.com/post/view?id=4370834</link><guid>https://investorshangout.com/post/view?id=4370834</guid><description><![CDATA[NotRichYet2
]]></description><pubDate>Tue, 21 Feb 2017 20:40:26 GMT</pubDate></item><item><title>chemist823: NTRP-&quot;Neurotrope BioScience (OTCQB:NTRP) is a three-year-old biotech company on the verge of releasi</title><link>https://investorshangout.com/post/view?id=4368579</link><guid>https://investorshangout.com/post/view?id=4368579</guid><description><![CDATA[chemist823
]]></description><pubDate>Tue, 21 Feb 2017 12:24:47 GMT</pubDate></item><item><title>chemist823: NTRP-I agree should gain some more ground because the market cap is to low for the promising data. A</title><link>https://investorshangout.com/post/view?id=4367795</link><guid>https://investorshangout.com/post/view?id=4367795</guid><description><![CDATA[chemist823
]]></description><pubDate>Mon, 20 Feb 2017 17:39:03 GMT</pubDate></item><item><title>NotRichYet2: NTRP will still move up for awhile but everything hinges on trial results in APRIL. Expectations are</title><link>https://investorshangout.com/post/view?id=4366410</link><guid>https://investorshangout.com/post/view?id=4366410</guid><description><![CDATA[NotRichYet2
]]></description><pubDate>Sun, 19 Feb 2017 14:53:49 GMT</pubDate></item><item><title>chemist823: NTRP- market cap less than 100 million at $14 per share, fair speculative value is about 250 million</title><link>https://investorshangout.com/post/view?id=4364181</link><guid>https://investorshangout.com/post/view?id=4364181</guid><description><![CDATA[chemist823
]]></description><pubDate>Fri, 17 Feb 2017 15:05:59 GMT</pubDate></item><item><title>chemist823: NTRP-&quot;We believe that we may have a breakthrough in Alzheimer&#039;s disease and other neurological disor</title><link>https://investorshangout.com/post/view?id=4361583</link><guid>https://investorshangout.com/post/view?id=4361583</guid><description><![CDATA[chemist823
]]></description><pubDate>Thu, 16 Feb 2017 15:09:26 GMT</pubDate></item><item><title>chemist823: NTRP- Trial results coming in April.</title><link>https://investorshangout.com/post/view?id=4361573</link><guid>https://investorshangout.com/post/view?id=4361573</guid><description><![CDATA[chemist823
]]></description><pubDate>Thu, 16 Feb 2017 15:07:28 GMT</pubDate></item><item><title>Emylers: NTRP Financials 07/16/2014 13:49:17 Neurotrope, Inc. Period Ending Dec 31, 2013 Jan 31, 2013 Dec 3</title><link>https://investorshangout.com/post/view?id=1668314</link><guid>https://investorshangout.com/post/view?id=1668314</guid><description><![CDATA[Emylers
]]></description><pubDate>Wed, 16 Jul 2014 18:49:13 GMT</pubDate></item><item><title>Stock_Tracker: Latest Neurotrope Inc. (NTRP) Headlines Neurotrope, Inc., Hires Three Experienced Sen</title><link>https://investorshangout.com/post/view?id=1315548</link><guid>https://investorshangout.com/post/view?id=1315548</guid><description><![CDATA[Stock_Tracker
]]></description><pubDate>Tue, 11 Mar 2014 00:21:18 GMT</pubDate></item><item><title>chartguy89: NTRP 2.75 Stock Charts $NTRP 1 Month Chart </title><link>https://investorshangout.com/post/view?id=1303673</link><guid>https://investorshangout.com/post/view?id=1303673</guid><description><![CDATA[chartguy89
]]></description><pubDate>Sun, 09 Mar 2014 03:38:31 GMT</pubDate></item><item><title>chartguy89: NTRP Stock Charts Last: +0.30 Friday, February 28, 2014 at 9:38:55 AM $NTRP 1 Mo</title><link>https://investorshangout.com/post/view?id=1265519</link><guid>https://investorshangout.com/post/view?id=1265519</guid><description><![CDATA[chartguy89
]]></description><pubDate>Fri, 28 Feb 2014 14:39:07 GMT</pubDate></item></channel></rss>